AVTX-006

News alerts, weekly reports and conference planners

Company:

Astellas, Avalo Therap

Drug class:

mTOR inhibitor, mTORC1 inhibitor, mTORC2 inhibitor

PTEN deletion	Ovarian Cancer	PTEN deletion	Ovarian Cancer	AVTX-006 Sensitive: D – Preclinical AVTX-006 Sensitive : D	AVTX-006 Sensitive: D – Preclinical AVTX-006 Sensitive : D
PIK3CA mutation	Ovarian Cancer	PIK3CA mutation	Ovarian Cancer	AVTX-006 Sensitive: D – Preclinical AVTX-006 Sensitive : D	AVTX-006 Sensitive: D – Preclinical AVTX-006 Sensitive : D

Associations
(2)